Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Moseley PM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Abdel-Fatah TMA; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; Department of Pathology, National Liver Institute, Menoufyia University, Al Minufya, Egypt., Ball GR; John van Geest Cancer Research Centre, Nottingham Trent University School of Science and Technology, Nottingham United Kingdom., Thangavelu PU; Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, Australia., Reid LE; UQ Centre for Clinical Research, Faculty of Research, The University of Queensland, Herston, Australia., McCart Reed AE; UQ Centre for Clinical Research, Faculty of Research, The University of Queensland, Herston, Australia., Saunus JM; UQ Centre for Clinical Research, Faculty of Research, The University of Queensland, Herston, Australia., Duijf PHG; Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, Australia., Simpson PT; UQ Centre for Clinical Research, Faculty of Research, The University of Queensland, Herston, Australia., Lakhani SR; UQ Centre for Clinical Research, Faculty of Research, The University of Queensland, Herston, Australia.; Pathology Queensland, The Royal Brisbane and Women's Hospital, Herston, Australia., Pongor L; Lendület Cancer Biomarker Research Group, Second Department of Pediatrics, Semmelweis University, Budapest, Hungary., Gyorffy B; Lendület Cancer Biomarker Research Group, Second Department of Pediatrics, Semmelweis University, Budapest, Hungary., Moseley PM; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Green AR; Nottingham Breast Cancer Research Center, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, United Kingdom., Pockley AG; John van Geest Cancer Research Centre, Nottingham Trent University School of Science and Technology, Nottingham United Kingdom., Caldas C; Department of Oncology and Cancer Research, UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom., Ellis IO; Nottingham Breast Cancer Research Center, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, United Kingdom., Chan SYT; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Publikováno v:
JAMA network open [JAMA Netw Open] 2020 Jul 01; Vol. 3 (7), pp. e209486. Date of Electronic Publication: 2020 Jul 01.
Autor:
Kotecha S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Lebot MN; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Sukkarn B; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Ball G; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham, NG1 4BU, UK., Moseley PM; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Chan SY; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Green AR; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Rakha E; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Ellis IO; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Martin SG; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Storr SJ; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK. sarah.storr@nottingham.ac.uk.
Publikováno v:
Scientific reports [Sci Rep] 2019 Nov 18; Vol. 9 (1), pp. 16987. Date of Electronic Publication: 2019 Nov 18.
Autor:
Abdel-Fatah TMA; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK., Ali R; Translational Oncology, Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG5 1PB, UK., Sadiq M; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK., Moseley PM; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK., Mesquita KA; Translational Oncology, Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG5 1PB, UK., Ball G; School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK., Green AR; Academic Pathology, Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG5 1PB, UK., Rakha EA; Academic Pathology, Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG5 1PB, UK., Chan SYT; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK. steve.chan@nuh.nhs.uk., Madhusudan S; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK. srinivasan.madhusudan@nottingham.ac.uk.; Translational Oncology, Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG5 1PB, UK. srinivasan.madhusudan@nottingham.ac.uk.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Aug 10; Vol. 11 (8). Date of Electronic Publication: 2019 Aug 10.
Autor:
Abdel-Fatah TMA; Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.; National Liver Institute, Menoufyia University, Menoufyia, Egypt., Broom RJ; Auckland City Hospital, Auckland, New Zealand., Lu J; The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China., Moseley PM; Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK., Huang B; The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, China., Li L; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Liu S; Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences, Shanghai Medical College, Key Laboratory of Breast Cancer in Shanghai, Cancer Institutes, Fudan University, Shanghai, China., Chen L; Laboratory of Molecular Biology, Zhengzhou Normal University, Zhengzhou, China., Ma RZ; Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China., Cao W; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Wang X; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Li Y; The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand., Perry JK; Liggins Institute, University of Auckland, Auckland, New Zealand., Aleskandarany M; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK., Nolan CC; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK., Rakha EA; Department of Histopathology, School of Medicine, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK., Lobie PE; Tsinghua Berkeley Shenzhen Institute, Tsinghua University, Shenzhen, Guangdong, China., Chan SYT; Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK., Ellis IO; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK., Hwang LA; p53 Laboratory, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Lane DP; p53 Laboratory, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Green AR; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK. andrew.green@nottingham.ac.uk., Liu DX; The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China. dong-xu.liu@aut.ac.nz.; The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand. dong-xu.liu@aut.ac.nz.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Apr; Vol. 120 (7), pp. 728-745. Date of Electronic Publication: 2019 Feb 28.
Autor:
Copson E; Cancer Sciences Academic Unit and Southampton Clinical Trials Unit, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK. Electronic address: E.Copson@soton.ac.uk., Shaaban AM; Department of Histopathology and University of Birmingham, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B152GW, UK., Maishman T; Cancer Sciences Academic Unit and Southampton Clinical Trials Unit, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK., Moseley PM; Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, NG5 1PB, UK., McKenzie H; Cancer Sciences Academic Unit and Southampton Clinical Trials Unit, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK., Bradbury J; Department of Oncology, Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ, UK., Borley A; Velindre Cancer Centre, Whitchurch, Cardiff, CF14 2TL, UK., Brzezinska M; Edinburgh Breast Unit, Western General Hospital, Edinburgh, Crewe Road South Edinburgh, EH4 2XU, UK., Chan SYT; Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, NG5 1PB, UK., Ching J; Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, BH15 2JB, UK., Cutress RI; Cancer Sciences Academic Unit and Southampton Clinical Trials Unit, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK., Danial I; Department of Histopathology and University of Birmingham, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B152GW, UK., Dall B; Breast Unit, Level 1 Chancellor Wing, St James Hospital, Leeds Teaching Hospitals NHS Trust, Becket Street, Leeds, LS9 7TF, UK., Kerin M; The Lambe Institute for Translational Research, National University of Ireland & University Hospital Galway, Galway, Ireland., Lowery AJ; The Lambe Institute for Translational Research, National University of Ireland & University Hospital Galway, Galway, Ireland., Macpherson IR; Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Romics L; Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK., Sawyer E; Research Oncology, Division of Cancer Studies, Guy's Hospital, King's College London, London, SE1 9RT, UK., Sharmat N; Breast Unit, Level 1 Chancellor Wing, St James Hospital, Leeds Teaching Hospitals NHS Trust, Becket Street, Leeds, LS9 7TF, UK., Sircar T; Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, WV10 0QP, UK., Vidya R; Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, WV10 0QP, UK., Pan Y; Centre for Computational Biology, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Rea D; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Jones L; Barts NHS Trust and Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK., Eccles DM; Cancer Sciences Academic Unit and Southampton Clinical Trials Unit, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK., Berditchevski F; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2018 Dec; Vol. 42, pp. 133-141. Date of Electronic Publication: 2018 Sep 15.
Autor:
Foulds GA; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom., Vadakekolathu J; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom., Abdel-Fatah TMA; Clinical Oncology Department, Nottingham University Hospitals, Nottingham, United Kingdom., Nagarajan D; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom., Reeder S; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom., Johnson C; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom., Hood S; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom., Moseley PM; Clinical Oncology Department, Nottingham University Hospitals, Nottingham, United Kingdom., Chan SYT; Clinical Oncology Department, Nottingham University Hospitals, Nottingham, United Kingdom., Pockley AG; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom., Rutella S; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom., McArdle SEB; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2018 Sep 11; Vol. 9, pp. 2028. Date of Electronic Publication: 2018 Sep 11 (Print Publication: 2018).
Autor:
Al-Subhi N; Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, NG5 1PB, UK., Ali R; Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, NG5 1PB, UK., Abdel-Fatah T; Department of Oncology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK., Moseley PM; Department of Oncology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK., Chan SYT; Department of Oncology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK., Green AR; Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, NG5 1PB, UK., Ellis IO; Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, NG5 1PB, UK., Rakha EA; Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, NG5 1PB, UK. emad.rakha@nottingham.ac.uk., Madhusudan S; Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, NG5 1PB, UK. srinivasan.madhusudan@nottingham.ac.uk.; Department of Oncology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK. srinivasan.madhusudan@nottingham.ac.uk.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Jun; Vol. 169 (2), pp. 277-286. Date of Electronic Publication: 2018 Feb 02.
Autor:
Naidoo K; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom., Wai PT; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, Centre for Evolution and Cancer and Centre for Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Maguire SL; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom., Daley F; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom., Haider S; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom., Kriplani D; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom., Campbell J; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom., Mirza H; Cancer Bioinformatics, Cancer Division, King's College London, London, United Kingdom., Grigoriadis A; Cancer Bioinformatics, Cancer Division, King's College London, London, United Kingdom., Tutt A; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.; Breast Cancer Now Research Unit, King's College London, London, United Kingdom., Moseley PM; Clinical Oncology, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom., Abdel-Fatah TMA; Clinical Oncology, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom., Chan SYT; Clinical Oncology, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom., Madhusudan S; Department of Histopathology and Division of Cancer & Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom., Rhaka EA; Department of Histopathology and Division of Cancer & Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom., Ellis IO; Department of Histopathology and Division of Cancer & Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom., Lord CJ; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom., Yuan Y; Division of Molecular Pathology, Centre for Evolution and Cancer and Centre for Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Green AR; Department of Histopathology and Division of Cancer & Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, United Kingdom., Natrajan R; The Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. rachael.natrajan@icr.ac.uk.; Division of Molecular Pathology, Centre for Evolution and Cancer and Centre for Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2018 Jan; Vol. 17 (1), pp. 306-315. Date of Electronic Publication: 2017 Nov 13.
Autor:
Machado LR; Faculty of Health and Society, University of Northampton, Boughton Green Road, Northampton, NN2 7AL, United Kingdom.; Department of Genetics, University of Leicester, Leicester, LE1 7RH, UK.; Faculty of Science, Technology, Engineering & Mathematics, The Open University, Milton Keynes, MK7 6AA, UK., Moseley PM; Clinical Oncology Department, Nottingham University Hospitals, Nottingham NG5 1PB, UK., Moss R; Academic Department of Clinical Oncology, Division of Cancer and Stem cells, City Hospital Campus, University of Nottingham, Nottingham NG5 1PB, UK., Deen S; Department of Histopathology, Nottingham University Hospitals NHS Trust, Queen's Medical Centre Campus Division of Clinical Pathology Division of Clinical Oncology, School of Molecular Medical Sciences, University of Nottingham, City Hospital Campus, Nottingham NG5 1PB, UK., Nolan C; Academic Department of Clinical Oncology, Division of Cancer and Stem cells, City Hospital Campus, University of Nottingham, Nottingham NG5 1PB, UK., Spendlove I; Academic Department of Clinical Oncology, Division of Cancer and Stem cells, City Hospital Campus, University of Nottingham, Nottingham NG5 1PB, UK., Ramage JM; Academic Department of Clinical Oncology, Division of Cancer and Stem cells, City Hospital Campus, University of Nottingham, Nottingham NG5 1PB, UK., Chan SY; Clinical Oncology Department, Nottingham University Hospitals, Nottingham NG5 1PB, UK., Durrant LG; Academic Department of Clinical Oncology, Division of Cancer and Stem cells, City Hospital Campus, University of Nottingham, Nottingham NG5 1PB, UK.
Publikováno v:
Oncotarget [Oncotarget] 2017 Aug 24; Vol. 8 (60), pp. 101215-101223. Date of Electronic Publication: 2017 Aug 24 (Print Publication: 2017).